Want to be on the show or have questions? Email Me! [email protected]

Today's episode discusses all things spinal cord stimulation, including exciting industry updates, the perils of insurance approvals, and new research that sets to expand upon current SCS concepts.

Sources for the SOLIS Trial:

https://neuronewsinternational.com/boston-scientific-solis-rct-nans-2023/

https://anesthesiology.weill.cornell.edu/research/anesthesiology-clinical-trials/clinical-trials-directory/a-randomized-controlled-study-to

Sources for Eterna IPG:

https://www.neuromodulation.abbott/us/en/chronic-pain/how-neurostimulation-treats/eterna-scs-system.html

https://abbott.mediaroom.com/2022-12-19-Abbott-Launches-the-Worlds-Smallest-Implantable,-Rechargeable-Spinal-Cord-Stimulation-System-for-Chronic-Pain

Sources for Post-Stroke SCS:

https://neuronewsinternational.com/spinal-cord-stimulation-instantly-improves-arm-hand-mobility-stroke/

https://microtransponder.com/en-gb/stroke/physicians/stroke-technology

https://nrtimes.co.uk/spinal-stimulation-improves-arm-function-after-stroke-ststory23/